GlassScriptPhysician profile
Jasmine Torrey
NPI 1912617317
$642.00
in general payments reported to CMS, 2019-2025
14 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $46.03 · 2024: $245 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $171.99 | 2024-2025 | |
| Janssen Biotech, INC. | $79.54 | 2023-2024 | Tremfya |
| Endo USA, INC. | $66.35 | 2024-2025 | Xiaflex |
| Painteq LLC | $54.27 | 2024 | Painteq |
| Amgen INC. | $44.48 | 2025 | Enbrel, Otezla, Tavneos |
| Bioventus LLC | $35.65 | 2025 | Exogen Ultrasound Bone Healing System |
| E.R. Squibb & Sons, L.L.C. | $34.01 | 2025 | Orencia |
| Smith+Nephew, INC. | $25.35 | 2025 | Evos |
| Ucb, INC. | $24.02 | 2024 | Cimzia |
| Nalu Medical, INC. | $23.17 | 2024 | Nalu Neurostimulation System |
| Genentech USA, INC. | $22.09 | 2025 | Actemra |
| Sonex Health, INC. | $21.71 | 2023 | Sx-One Microknife |
| Sandoz INC. | $20.20 | 2025 | Hyrimoz |
| Endo Pharmaceuticals INC. | $19.17 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Torrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.